Patents by Inventor Gregory J. Fisk

Gregory J. Fisk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Micro-movement and gesture detection using radar
    Patent number: 11918331
    Abstract: A movement detection device includes a signal transmission device configured to transmit a radar signal transmission toward a target area and to receive reflected radar signals, and a signal analysis device configured to analyze the reflected radar signals to detect a movement in the target area that is indicative of micro-shivering. In response to detecting the micro-shivering, the movement detection device generates an alarm.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: March 5, 2024
    Assignee: Hill-Rom Services, Inc.
    Inventors: Steven D. Baker, Jennifer Bergstrom, Heinz-Hermann Dalbert, Brandon P. Fisk, Yongji Fu, Michael S. Hood, Charles A. Lachenbruch, John A. Lane, Kenzi L. Mudge, Matthew O'Neal, Frank E. Sauser, Douglas A. Seim, Gregory J. Shannon
  • Drug screening using islet cells and islet cell progenitors from human embryonic stem cells
    Patent number: 9085756
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: July 21, 2015
    Assignee: Asterias Biotherapeutic, Inc.
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Islet Cells From Human Embryonic Stem Cells
    Publication number: 20140342452
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: June 25, 2014
    Publication date: November 20, 2014
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
    Publication number: 20110065118
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: November 16, 2010
    Publication date: March 17, 2011
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
    Publication number: 20100196916
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 5, 2010
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
    Publication number: 20090325180
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: August 19, 2009
    Publication date: December 31, 2009
    Inventors: GREGORY J. FISK, MARGARET S. INOKUMA
  • Islet Cells from Human Embryonic Stem Cells
    Publication number: 20090093055
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: October 31, 2008
    Publication date: April 9, 2009
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Islet Cells from Human Embryonic Stem Cells
    Publication number: 20080145889
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 19, 2008
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Endoderm cells from human embryonic stem cells
    Patent number: 7326572
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: February 5, 2008
    Assignee: Geron Corporation
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Islet cells from human embryonic stem cells
    Patent number: 7033831
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Grant
    Filed: December 6, 2002
    Date of Patent: April 25, 2006
    Assignee: Geron Corporation
    Inventors: Gregory J. Fisk, Margaret S. Inokuma
  • Islet cells from human embryonic stem cells
    Publication number: 20030138948
    Abstract: This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
    Type: Application
    Filed: December 6, 2002
    Publication date: July 24, 2003
    Inventors: Gregory J. Fisk, Margaret S. Inokuma